Published in Biol Mood Anxiety Disord on September 27, 2011
Genetic approaches for understanding the role of serotonin receptors in mood and behavior. Curr Opin Neurobiol (2013) 0.87
Identifying serotonergic mechanisms underlying the corticolimbic response to threat in humans. Philos Trans R Soc Lond B Biol Sci (2013) 0.81
Top-Down Control of Serotonin Systems by the Prefrontal Cortex: A Path toward Restored Socioemotional Function in Depression. ACS Chem Neurosci (2015) 0.81
Fluctuations in [¹¹C]SB207145 PET binding associated with change in threat-related amygdala reactivity in humans. Neuropsychopharmacology (2015) 0.81
Oestradiol alters central 5-HT1A receptor binding potential differences related to psychosocial stress but not differences related to 5-HTTLPR genotype in female rhesus monkeys. J Neuroendocrinol (2014) 0.80
Strain-dependent variations in stress coping behavior are mediated by a 5-HT/GABA interaction within the prefrontal corticolimbic system. Int J Neuropsychopharmacol (2014) 0.79
Differential effects of sertraline in a predator exposure animal model of post-traumatic stress disorder. Front Behav Neurosci (2014) 0.78
Acute effects of Sceletium tortuosum (Zembrin), a dual 5-HT reuptake and PDE4 inhibitor, in the human amygdala and its connection to the hypothalamus. Neuropsychopharmacology (2013) 0.78
Presynaptic Serotoninergic Regulation of Emotional Processing: A Multimodal Brain Imaging Study. Biol Psychiatry (2014) 0.75
Emotion moderates the association between HTR2A (rs6313) genotype and antisaccade latency. Exp Brain Res (2016) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage (2003) 24.48
Improved assessment of significant activation in functional magnetic resonance imaging (fMRI): use of a cluster-size threshold. Magn Reson Med (1995) 21.06
Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp (2000) 15.98
5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci (2005) 10.13
Serotonin transporter genetic variation and the response of the human amygdala. Science (2002) 9.31
Extinction learning in humans: role of the amygdala and vmPFC. Neuron (2004) 8.63
Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology (2007) 7.57
Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab (1990) 6.62
A review of central 5-HT receptors and their function. Neuropharmacology (1999) 6.13
Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J Comp Neurol (1989) 4.96
Stimulation of medial prefrontal cortex decreases the responsiveness of central amygdala output neurons. J Neurosci (2003) 4.91
Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis. Biol Psychiatry (2007) 4.71
A susceptibility gene for affective disorders and the response of the human amygdala. Arch Gen Psychiatry (2005) 4.33
A functional magnetic resonance imaging study of amygdala and medial prefrontal cortex responses to overtly presented fearful faces in posttraumatic stress disorder. Arch Gen Psychiatry (2005) 4.07
Pathways for emotion: interactions of prefrontal and anterior temporal pathways in the amygdala of the rhesus monkey. Neuroscience (2002) 3.86
The amygdala response to emotional stimuli: a comparison of faces and scenes. Neuroimage (2002) 3.70
Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat Neurosci (2004) 3.56
Anatomic basis of cognitive-emotional interactions in the primate prefrontal cortex. Neurosci Biobehav Rev (1995) 3.28
Individual differences in trait anxiety predict the response of the basolateral amygdala to unconsciously processed fearful faces. Neuron (2004) 3.26
Inhibited and uninhibited infants "grown up": adult amygdalar response to novelty. Science (2003) 2.91
Prefrontal control of the amygdala. J Neurosci (2005) 2.39
The structural integrity of an amygdala-prefrontal pathway predicts trait anxiety. J Neurosci (2009) 2.35
A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol Psychiatry (2000) 2.32
Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biol Psychiatry (2006) 2.30
Comparative evaluation of MR-based partial-volume correction schemes for PET. J Nucl Med (1999) 2.30
Imaging genetics: perspectives from studies of genetically driven variation in serotonin function and corticolimbic affective processing. Biol Psychiatry (2006) 2.29
Correction of PET data for partial volume effects in human cerebral cortex by MR imaging. J Comput Assist Tomogr (1990) 2.09
Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans: comparison of arterial and reference tisssue input functions. J Cereb Blood Flow Metab (2000) 1.77
Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease. Neurosci Biobehav Rev (2008) 1.65
5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proc Natl Acad Sci U S A (1998) 1.61
Novelty responses and differential effects of order in the amygdala, substantia innominata, and inferior temporal cortex. Neuroimage (2003) 1.59
Differential amygdalar response to novel versus newly familiar neutral faces: a functional MRI probe developed for studying inhibited temperament. Biol Psychiatry (2003) 1.57
5-hydroxytryptamine 2C receptors in the basolateral amygdala are involved in the expression of anxiety after uncontrollable traumatic stress. Biol Psychiatry (2009) 1.55
Genetic variation in MAOA modulates ventromedial prefrontal circuitry mediating individual differences in human personality. Mol Psychiatry (2007) 1.54
Effects of HTR1A C(-1019)G on amygdala reactivity and trait anxiety. Arch Gen Psychiatry (2009) 1.51
Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex. Cereb Cortex (2004) 1.48
Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study. Neuropsychopharmacology (2006) 1.45
Capacity for 5-HT1A-mediated autoregulation predicts amygdala reactivity. Nat Neurosci (2006) 1.40
Immunocytochemical localization of serotonin1A receptors in the rat central nervous system. J Comp Neurol (1996) 1.39
Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT(2C) receptor antagonist. Biol Psychiatry (2007) 1.36
Acute 5-HT reuptake blockade potentiates human amygdala reactivity. Neuropsychopharmacology (2008) 1.36
Serotonin 1A receptor binding and treatment response in late-life depression. Neuropsychopharmacology (2004) 1.35
Functional changes in the activity of brain regions underlying emotion processing in the elderly. Psychiatry Res (2005) 1.28
Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100,907. Am J Psychiatry (2006) 1.27
Differential innervation of parvalbumin-immunoreactive interneurons of the basolateral amygdaloid complex by cortical and intrinsic inputs. J Comp Neurol (2000) 1.27
Medial prefrontal cortex 5-HT(2A) density is correlated with amygdala reactivity, response habituation, and functional coupling. Cereb Cortex (2009) 1.26
Cellular localization of the 5-HT1A receptor in primate brain neurons and glial cells. Neuropsychopharmacology (1996) 1.23
Gender-specific decrease in NUDR and 5-HT1A receptor proteins in the prefrontal cortex of subjects with major depressive disorder. Int J Neuropsychopharmacol (2008) 1.22
Ultrastructural localization of serotonin2A receptors in the middle layers of the rat prelimbic prefrontal cortex. Neuroscience (2003) 1.21
Exaggerated 5-HT1A but normal 5-HT2A receptor activity in individuals ill with anorexia nervosa. Biol Psychiatry (2007) 1.17
Human 5-HT transporter availability predicts amygdala reactivity in vivo. J Neurosci (2007) 1.16
Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder. Biol Psychiatry (2007) 1.15
Neuronal localization of 5-HT type 2A receptor immunoreactivity in the rat basolateral amygdala. Neuroscience (2007) 1.13
Inverse relationship between serotonin 5-HT(1A) receptor binding and anxiety: a [(11)C]WAY-100635 PET investigation in healthy volunteers. Am J Psychiatry (2001) 1.12
In vivo modulation of the activity of pyramidal neurons in the rat medial prefrontal cortex by 5-HT2A receptors: relationship to thalamocortical afferents. Cereb Cortex (2003) 1.12
Modulation of the activity of pyramidal neurons in rat prefrontal cortex by raphe stimulation in vivo: involvement of serotonin and GABA. Cereb Cortex (2004) 1.09
The 5-HT1A serotonin receptor is located on calbindin- and parvalbumin-containing neurons in the rat brain. Brain Res (2003) 1.08
Gender-specific aging effects on the serotonin 1A receptor. Brain Res (2001) 1.08
Changes in anxiety-related behaviors and hypothalamic-pituitary-adrenal activity in mice lacking the 5-HT-3A receptor. Physiol Behav (2004) 1.03
Quantitative analysis of glutamatergic and GABAergic neurons expressing 5-HT(2A) receptors in human and monkey prefrontal cortex. J Neurochem (2007) 0.99
Altered 5-HT(2A) receptor binding after recovery from bulimia-type anorexia nervosa: relationships to harm avoidance and drive for thinness. Neuropsychopharmacology (2004) 0.98
Anticipatory cues differentially provoke in vivo peptidergic and monoaminergic release at the medial prefrontal cortex. Neuropsychopharmacology (2004) 0.96
Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain. Synapse (1998) 0.94
Increased expression of 5-HT1B receptor in dorsal raphe nucleus decreases fear-potentiated startle in a stress dependent manner. Brain Res (2004) 0.92
Reduced binding of [18F]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correction. Brain Res (1998) 0.92
Fluorine-18-altanserin: a radioligand for the study of serotonin receptors with PET: radiolabeling and in vivo biologic behavior in rats. J Nucl Med (1991) 0.89
Asymmetrical involvement of mesolimbic dopaminergic neurons in affective perception. Neuroscience (1995) 0.89
Valence dependent asymmetric release of norepinephrine in the basolateral amygdala. Behav Neurosci (2010) 0.87
Serotonin 1A receptors in human and monkey prefrontal cortex are mainly expressed in pyramidal neurons and in a GABAergic interneuron subpopulation: implications for schizophrenia and its treatment. J Neurochem (2008) 0.87
Analyses of [(18)F]altanserin bolus injection PET data. II: consideration of radiolabeled metabolites in humans. Synapse (2001) 0.84
Gender, personality, and serotonin-2A receptor binding in healthy subjects. Psychiatry Res (2010) 0.84
Serotonin1A receptors at the axon initial segment of prefrontal pyramidal neurons in schizophrenia. Am J Psychiatry (2004) 0.84
Mesocortical dopamine and HPA axis regulation: role of laterality and early environment. Brain Res (2006) 0.83
Analyses of [(18)F] altanserin bolus injection PET data. I: consideration of radiolabeled metabolites in baboons. Synapse (2001) 0.80
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol (2004) 21.56
Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab (2007) 11.79
5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci (2005) 10.13
Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol (2008) 7.95
Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. J Cereb Blood Flow Metab (2005) 6.25
Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry (2010) 6.15
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain (2008) 5.89
Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A (2009) 5.55
Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. J Nucl Med (2005) 5.10
Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis. Biol Psychiatry (2007) 4.71
Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci U S A (2003) 4.21
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol (2007) 4.11
Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. Am J Psychiatry (2009) 3.94
Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J Neurosci (2007) 3.91
The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core. Alzheimers Dement (2010) 3.30
Altered striatal activation predicting real-world positive affect in adolescent major depressive disorder. Am J Psychiatry (2008) 3.01
Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. J Neurosurg (2005) 2.87
Functional neuroimaging evidence for hyperarousal in insomnia. Am J Psychiatry (2004) 2.87
Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc Natl Acad Sci U S A (2005) 2.68
Amyloid imaging in mild cognitive impairment subtypes. Ann Neurol (2009) 2.66
Genetic variation in human NPY expression affects stress response and emotion. Nature (2008) 2.65
Postpartum depression: a randomized trial of sertraline versus nortriptyline. J Clin Psychopharmacol (2006) 2.64
Neural correlates of genetically abnormal social cognition in Williams syndrome. Nat Neurosci (2005) 2.50
Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proc Natl Acad Sci U S A (2004) 2.36
Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain. J Neurosci (2005) 2.17
A fully automated method for quantifying and localizing white matter hyperintensities on MR images. Psychiatry Res (2006) 2.08
Timing of hormone therapy, type of menopause, and coronary disease in women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Menopause (2011) 2.06
Neurophysiological correlates of age-related changes in working memory capacity. Neurosci Lett (2005) 2.06
Cognitive impairment associated with adjuvant therapy in breast cancer. Psychooncology (2006) 2.06
Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer. Menopause (2007) 2.04
Perigenual anterior cingulate morphology covaries with perceived social standing. Soc Cogn Affect Neurosci (2007) 1.98
Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation. Arch Gen Psychiatry (2006) 1.94
Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve. J Neurosci (2009) 1.89
PET/CT: form and function. Radiology (2007) 1.89
Neural correlates of facial affect processing in children and adolescents with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry (2004) 1.89
Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl Med Biol (2007) 1.87
Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults. Biol Psychiatry (2008) 1.85
Individual differences in stressor-evoked blood pressure reactivity vary with activation, volume, and functional connectivity of the amygdala. J Neurosci (2008) 1.83
Serotonin 1A receptor reductions in postpartum depression: a positron emission tomography study. Fertil Steril (2007) 1.82
Increased dopamine D2/D3 receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [11c]raclopride. Biol Psychiatry (2005) 1.80
Onset timing, thoughts of self-harm, and diagnoses in postpartum women with screen-positive depression findings. JAMA Psychiatry (2013) 1.80
Individual differences in typical reappraisal use predict amygdala and prefrontal responses. Biol Psychiatry (2008) 1.77
Regional cerebral metabolic correlates of WASO during NREM sleep in insomnia. J Clin Sleep Med (2006) 1.76
Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's disease. Neuroimage (2006) 1.65
Developmental change in amygdala reactivity during adolescence: effects of family history of depression and stressful life events. Am J Psychiatry (2014) 1.63
Hormone replacement therapy formulations and risk of epithelial ovarian carcinoma. Gynecol Oncol (2002) 1.60
Head and neck malignancy: is PET/CT more accurate than PET or CT alone? Radiology (2005) 1.59
Serotonin transporter binding after recovery from eating disorders. Psychopharmacology (Berl) (2007) 1.57
Determination of menopausal status in women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. J Womens Health (Larchmt) (2004) 1.57
Brain imaging findings predict blood pressure response to pharmacological treatment. Hypertension (2008) 1.52
Effects of HTR1A C(-1019)G on amygdala reactivity and trait anxiety. Arch Gen Psychiatry (2009) 1.51
Human regional cerebral glucose metabolism during non-rapid eye movement sleep in relation to waking. Brain (2002) 1.50
Pulsatile luteinizing hormone amplitude and progesterone metabolite excretion are reduced in obese women. J Clin Endocrinol Metab (2007) 1.50
Is there a general factor of prevalent psychopathology during adulthood? J Abnorm Psychol (2012) 1.49
Temporal stability of individual differences in amygdala reactivity. Am J Psychiatry (2007) 1.47
Does lifetime exposure to hormones predict pretreatment cognitive function in women before adjuvant therapy for breast cancer? Menopause (2013) 1.46
Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B. J Neurosci Methods (2008) 1.46
Issues, controversies, and clinical utility of combined PET/CT imaging: what is the interpreting physician facing? AJR Am J Roentgenol (2005) 1.44
Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study. J Am Coll Cardiol (2003) 1.44
Adenylate cyclase 7 is implicated in the biology of depression and modulation of affective neural circuitry. Biol Psychiatry (2012) 1.43
Potential neural embedding of parental social standing. Soc Cogn Affect Neurosci (2008) 1.42
Multilocus genetic profile for dopamine signaling predicts ventral striatum reactivity. Neuropsychopharmacology (2011) 1.41
Neural basis of individual differences in impulsivity: contributions of corticolimbic circuits for behavioral arousal and control. Emotion (2006) 1.40
Dopamine modulates the response of the human amygdala: a study in Parkinson's disease. J Neurosci (2002) 1.38
Acute 5-HT reuptake blockade potentiates human amygdala reactivity. Neuropsychopharmacology (2008) 1.36
The neural signatures of distinct psychopathic traits. Soc Neurosci (2012) 1.35
Cerebral ventricular changes associated with transitions between normal cognitive function, mild cognitive impairment, and dementia. Alzheimer Dis Assoc Disord (2007) 1.35
The BOLD hemodynamic response in healthy aging. J Cogn Neurosci (2004) 1.35
Gray matter changes in late life depression--a structural MRI analysis. Neuropsychopharmacology (2007) 1.35
Serotonin transporter genotype (5-HTTLPR): effects of neutral and undefined conditions on amygdala activation. Biol Psychiatry (2006) 1.35
Serotonin 1A receptor binding and treatment response in late-life depression. Neuropsychopharmacology (2004) 1.35
Evidence that altered amygdala activity in schizophrenia is related to clinical state and not genetic risk. Am J Psychiatry (2008) 1.33
Normal brain tissue volumes after long-term recovery in anorexia and bulimia nervosa. Biol Psychiatry (2005) 1.32
Imaging Alzheimer pathology in late-life depression with PET and Pittsburgh Compound-B. Alzheimer Dis Assoc Disord (2008) 1.30
Dopamine in amygdala gates limbic processing of aversive stimuli in humans. Nat Neurosci (2008) 1.29
Functional changes in the activity of brain regions underlying emotion processing in the elderly. Psychiatry Res (2005) 1.28
MR∕PET quantification tools: registration, segmentation, classification, and MR-based attenuation correction. Med Phys (2012) 1.28
Consideration of optimal time window for Pittsburgh compound B PET summed uptake measurements. J Nucl Med (2009) 1.27
Medial prefrontal cortex 5-HT(2A) density is correlated with amygdala reactivity, response habituation, and functional coupling. Cereb Cortex (2009) 1.26
Synergism between psychosocial and metabolic stressors: impact on reproductive function in cynomolgus monkeys. Am J Physiol Endocrinol Metab (2007) 1.23
Interaction between trait anxiety and trait anger predict amygdala reactivity to angry facial expressions in men but not women. Soc Cogn Affect Neurosci (2010) 1.23
Neuroimaging studies of serotonin gene polymorphisms: exploring the interplay of genes, brain, and behavior. Cogn Affect Behav Neurosci (2006) 1.21
Long-chain omega-3 fatty acid intake is associated positively with corticolimbic gray matter volume in healthy adults. Neurosci Lett (2007) 1.20
Ventral striatum reactivity to reward and recent life stress interact to predict positive affect. Biol Psychiatry (2012) 1.20
Perceived social support moderates the link between threat-related amygdala reactivity and trait anxiety. Neuropsychologia (2010) 1.19
Imaging technology for neurodegenerative diseases: progress toward detection of specific pathologies. Arch Neurol (2005) 1.18
Classification of amyloid-positivity in controls: comparison of visual read and quantitative approaches. Neuroimage (2013) 1.17